254 related articles for article (PubMed ID: 11641594)
1. Post-stroke depression, antidepressant treatment and rehabilitation results. A case-control study.
Paolucci S; Antonucci G; Grasso MG; Morelli D; Troisi E; Coiro P; De Angelis D; Rizzi F; Bragoni M
Cerebrovasc Dis; 2001; 12(3):264-71. PubMed ID: 11641594
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of milnacipran on poststroke depression on inpatient rehabilitation.
Yamakawa Y; Satoh S; Sawa S; Ohta H; Asada T
Psychiatry Clin Neurosci; 2005 Dec; 59(6):705-10. PubMed ID: 16401247
[TBL] [Abstract][Full Text] [Related]
3. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
[TBL] [Abstract][Full Text] [Related]
5. Fluoxetine in early poststroke depression: a double-blind placebo-controlled study.
Wiart L; Petit H; Joseph PA; Mazaux JM; Barat M
Stroke; 2000 Aug; 31(8):1829-32. PubMed ID: 10926942
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
Li L; Han Z; Li L; Han L; Yan B
J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
[TBL] [Abstract][Full Text] [Related]
7. Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine.
Greist J; McNamara RK; Mallinckrodt CH; Rayamajhi JN; Raskin J
Clin Ther; 2004 Sep; 26(9):1446-55. PubMed ID: 15531007
[TBL] [Abstract][Full Text] [Related]
8. Effects of antidepressant treatment on N-acetyl aspartate and choline levels in the hippocampus and thalami of post-stroke depression patients: a study using (1)H magnetic resonance spectroscopy.
Huang Y; Chen W; Li Y; Wu X; Shi X; Geng D
Psychiatry Res; 2010 Apr; 182(1):48-52. PubMed ID: 20227856
[TBL] [Abstract][Full Text] [Related]
9. Motor and functional recovery in patients with post-stroke depression.
Nannetti L; Paci M; Pasquini J; Lombardi B; Taiti PG
Disabil Rehabil; 2005 Feb; 27(4):170-5. PubMed ID: 15824047
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of paroxetine in the treatment of poststroke depression.
Ma C; Li P
Medicine (Baltimore); 2018 Jul; 97(29):e11496. PubMed ID: 30024530
[TBL] [Abstract][Full Text] [Related]
11. The beneficial effects of the herbal medicine Free and Easy Wanderer Plus (FEWP) and fluoxetine on post-stroke depression.
Li LT; Wang SH; Ge HY; Chen J; Yue SW; Yu M
J Altern Complement Med; 2008 Sep; 14(7):841-6. PubMed ID: 18721085
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine for the prophylaxis of poststroke depression in patients with stroke: a meta-analysis.
Yi ZM; Liu F; Zhai SD
Int J Clin Pract; 2010 Aug; 64(9):1310-7. PubMed ID: 20653802
[TBL] [Abstract][Full Text] [Related]
13. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
Jorge RE; Robinson RG; Arndt S; Starkstein S
Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effectiveness and safety of paroxetine in post-stroke depression: results from a phase 4, open label, multicenter clinical trial with 26 weeks of follow-up].
Horváth S; Karányi Z; Harcos P; Nagy Z; Németh G; Andor G
Orv Hetil; 2006 Dec; 147(50):2397-404. PubMed ID: 17274185
[TBL] [Abstract][Full Text] [Related]
15. Effect of antidepressants on the course of disability following stroke.
Mikami K; Jorge RE; Adams HP; Davis PH; Leira EC; Jang M; Robinson RG
Am J Geriatr Psychiatry; 2011 Dec; 19(12):1007-15. PubMed ID: 21358384
[TBL] [Abstract][Full Text] [Related]
16. Post-stroke Depression Increases Disability More Than 15% in Ischemic Stroke Survivors: A Case-Control Study.
Paolucci S; Iosa M; Coiro P; Venturiero V; Savo A; De Angelis D; Morone G
Front Neurol; 2019; 10():926. PubMed ID: 31507525
[TBL] [Abstract][Full Text] [Related]
17. Poststroke depression and its multifactorial nature: results from a prospective longitudinal study.
De Ryck A; Fransen E; Brouns R; Geurden M; Peij D; Mariën P; De Deyn PP; Engelborghs S
J Neurol Sci; 2014 Dec; 347(1-2):159-66. PubMed ID: 25451004
[TBL] [Abstract][Full Text] [Related]
18. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window?
Narushima K; Robinson RG
J Nerv Ment Dis; 2003 Oct; 191(10):645-52. PubMed ID: 14555866
[TBL] [Abstract][Full Text] [Related]
19. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery.
Bilge C; Koçer E; Koçer A; Türk Börü U
Eur J Phys Rehabil Med; 2008 Mar; 44(1):13-8. PubMed ID: 18385623
[TBL] [Abstract][Full Text] [Related]
20. Fluoxetine improves the quality of life in patients with poststroke emotional disturbances.
Choi-Kwon S; Choi J; Kwon SU; Kang DW; Kim JS
Cerebrovasc Dis; 2008; 26(3):266-71. PubMed ID: 18648199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
